We are live on ! Find out more
SSCM

Sovereign's Capital Management Portfolio holdings

AUM $136M
1-Year Est. Return 5.11%
This Fund
S&P 500
This Quarter Est. Return
-8.96%
1 Year Est. Return
-5.11%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$136M
AUM Growth
-$29M
Cap. Flow
-$14.6M
Cap. Flow %
-10.76%
Top 10 Hldgs %
37.04%
Holding
82
New
4
Increased
13
Reduced
59
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 31.89%
2 Financials 19.11%
3 Industrials 10.98%
4 Healthcare 10.33%
5 Consumer Discretionary 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAVA icon
76
Endava
DAVA
$141M
$75K 0.06%
16,971
-1,248
-7% -$6.89K
ADV icon
77
Advantage Solutions
ADV
$484M
-8,945
Closed -$197K
BDX icon
78
Becton Dickinson
BDX
$43.1B
-1,459
Closed -$283K
CSWC icon
79
Capital Southwest
CSWC
$1.46B
-76,522
Closed -$1.69M
FOLD
80
DELISTED
Amicus Therapeutics
FOLD
-784,942
Closed -$11.2M
HUBS icon
81
HubSpot
HUBS
$10.5B
-805
Closed -$323K
SMCI icon
82
Super Micro Computer
SMCI
$19.5B
-48,846
Closed -$1.43M

Similar funds

Sovereign's Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Sovereign's Capital Management held 82 positions worth $136M, down 18% from $165M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sovereign's Capital Management withdrew a net $14.6M in Q1 2026, closing 6 positions and reducing 59 holdings. Its most notable exit was Amicus Therapeutics, an estimated $11.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Financials and Industrials.

Against the trend, Sovereign's Capital Management opened a new position in Fidelity National Information Services worth $2.82M.

  • Sovereign's Capital Management's largest Q1 2026 buy was Fidelity National Information Services: 60,145 shares worth $2.82M.
  • Sovereign's Capital Management added most to Paycom in Q1 2026, an estimated $2.38M increase.
  • Sovereign's Capital Management's biggest Q1 2026 reduction was LCI Industries, cutting an estimated $3.3M.
  • Sovereign's Capital Management fully exited Amicus Therapeutics in Q1 2026, selling an estimated $11.2M.
  • Sovereign's Capital Management's ten largest holdings make up 37% of its $136M portfolio in Q1 2026.
  • Sovereign's Capital Management opened 4 new positions and closed 6 in Q1 2026.
  • Sovereign's Capital Management's portfolio value fell 18% quarter-over-quarter to $136M.

Based on Sovereign's Capital Management's 13F filing for Q1 2026, filed 15 May 2026.